Table 1 Basic clinical characteristics of the patients
Patients (n) | 184 | |
|---|---|---|
Age (years) | Median, Mean (Range, SD) | 54, 53.3 (31–81, 10.3) |
BMI (kg/m2) | Median, Mean (Range, SD) | 22.59, 23.1 (16.2–33.8, 3.3) |
Duration of EBRT (days) | Median, Mean (Range, SD) | 37, 38 (29–52, 3.9) |
RT dose to pelvis (Gy) | Median, Mean (Range, SD) | 45, 47.4 (45–50.4, 2.6) |
Cycles of chemotherapy | Median, Mean (Range, SD) | 2, 2.9 (1–6, 1.5) |
Clinical stage FIGO2018 (n, %) | IB–IIB IIIA–IVB | 98 (53.3) 86 (46.7) |
Histology, n (%) | Squamous carcinoma Adenocarcinoma | 166 (90.2) 18 (9.8) |
Differentiation degree, n (%) | High–moderate Lower / Unknown | 85 (46.2) 99 (53.8) |
PTV dose-pelvis (n, %) | 45 Gy 48.6 Gy–50.4 Gy | 99 (53.8) 85 (46.2) |
Chemotherapy regimen (n, %) | TP Carboplatin Cisplatin | 42 (22.8) 31 (16.9) 111 (60.3) |